Dissertação Final - Hospital Veterinário do Baixo Vouga

Referências bibliográficas
• Vail, DM. 2009; Supporting the Veterinary Cancer Patient on Chemotherapy:
Neutropenia and Gastrintestinal Toxicity. Saunders Elsevier;
• Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM. 1997. Doxorubicin alone or in
combination with asparginase, fllowed by ciclofosfamide, vincristine, and prednisone for
treatment of multicentric lymphoma in dogs: 121 cases (1987.1995). J Am Vet Med Ass;
• Veterinary Co-operative Oncology Group. Veterinary cooperative oncology group
common terminology criteria for adverse events (VCOG-CTCAE) following
chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. 2004. Vet
Compar Oncol 2:194–213;
• Weir EC, Norrdin RW, Matus RE, Brooks MB, Broadus AE, Mitnick M, Johnston
SD, Insogna KL. 1988. Humoral hypercalcemia of malignancy in canine lymphosarcoma.
Endocrinology 122: 602–608;
• Withrow SJ et Khanna C. 2010. Bridging the gap between experimental animals and
humans in osteossarcoma. Cancer treatment and research Vol:152, 439-446;
• Withrow SJ, Vail DM. Withrow and MacEwen’s. 2007. Canine lymphoma and lymphoid
leukemias. In: Small Animal Clinical Oncoloy (4ed); Missouri: Saunders Elsivier;
• World Health Organization. 1980. TNM Classification of tumours in Domestic Animals,
Geneva. WHO Pr.
61